Genomic Health will present results from its first biomarker study using next-generation sequencing at the San Antonio Breast Cancer Symposium in December, company officials said this week.

CEO Kim Popovits said during a call to discuss the company's third-quarter earnings this week that the study was one of 16 abstracts accepted for presentation at the annual conference.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.